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Abstract
Background: Hand foot mouth disease (HFMD) is a common childhood infection that can potentially lead to
serious complications. The aim of this study is to identify risk factors of acquiring severe HFMD in our population.
Methods: We performed a case control study using patients admitted to our hospital from August 2004 to July 2014.
Cases were patients with severe HFMD disease while controls were age-matched patients obtained from the same
year, in a 2:1 ratio. Data comprising demographic characteristics, clinical symptoms and signs, and lab findings were
collected. Conditional univariable logistic regression was performed to determine risk factors for severe disease.
Results: A total of 24 cases of severe HFMD were identified and matched with 48 controls. Seventeen (70.8 %) cases
had central nervous system complications. Seven (29.2 %) had cardiovascular complications without evidence of
myocarditis. One patient died of encephalitis. The overall mortality of severe disease is 4 %. Evidence of hypoperfusion,
seizure, altered mentation, meningeal irritation, tachycardia, tachypnea, raised absolute neutrophil count and EV-A71
(Enterovirus A71) positivity were significantly associated with a severe course of HFMD.
Conclusion: In managing children with HFMD, physicians should consider these factors to help identify patients at risk
for severe disease.
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Background
Hand foot and mouth disease (HFMD) is a common
childhood infection characterized typically by fever with
mouth ulcers, eruption of vesiculo-papular rash over the
hands, soles and/or buttocks. It is caused by a group of
enteroviruses, most frequently Coxsackie A16 and
Enterovirus-A71 (EV-A71). The mode of transmission of
HFMD is mainly via the fecal-oral route, respiratory
droplets, contact with blister fluid of an infected individ-
ual or general close contact with infected individuals.
HFMD is a significant public health disease with epi-
demics reported frequently throughout Asia [1].
While the majority of HFMD cases are mild and self-
limiting, severe complications such as encephalitis, men-
ingitis, acute flaccid paralysis, myocarditis and pulmonary
edema have been reported [2–4]. These complications
may result in significant morbidity or even mortality. In
recent years, outbreaks of HFMD have been increasingly
reported in eastern and southeastern Asia, including
Singapore [5], Malaysia [3], Vietnam [6], mainland China
[7] and Taiwan [4]. The clinical challenge for physicians
caring for children with HFMD is the difficulty in predict-
ing which child will develop a severe course of disease.
This is due to the non-specific complaints of children and
their variable clinical presentations. Previous studies,
largely from China, have been performed to identify risk
factors associated with severe HFMD [5, 7–11]. The only
local study was done more than a decade ago [5].
Over the last decade, nationwide epidemics in Singapore
were observed in years 2002, 2005, 2006 and 2007 [1].
Despite stringent measures taken in pre-school centres to
prevent the transmission of infection in our country, the
annual incidence rate of HFMD per 100,000 population
had increased from 125.5 in 2001 to 435.9 in 2007 [12].
In this study, we aim to identify risk factors of acquir-
ing severe HFMD in our population. These would be
categorized firstly as information readily available from
history and physical examination, and then other labora-
tory predictors when available and accessible. We
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hypothesized that lethargy, vomiting, raised neutro-
phil count and EV-A71 infection are risk factors for
severe HFMD.
Methods
This age-matched case–control study was approved by
the Singapore Centralised Institutional Review Board
(CIRB) E (Paediatric Medicine). We obtained cases and
controls from a retrospective chart review of patients ad-
mitted with the International Classification of Diseases
(ICD) code for HFMD from August 2004 to July 2014.
HFMD was clinically defined as the presence of papular/
vesicular skin rash on the hand, feet/buttocks and oral ul-
cers in association with an acute prodrome of fever [1]. A
case subject was defined as a child with severe disease
characterized by any of the following clinical outcomes:
death, encephalitis, meningitis, myocarditis, pulmonary
edema or acute flaccid paralysis (AFP). Encephalitis and
meningitis were characterized by abnormal neuroimaging
or postmortem examination, biochemical abnormalities on
cerebrospinal fluid, clinical documentation of meningeal ir-
ritation, altered mentation or seizures. Myocarditis was
characterized by raised cardiac enzymes or abnormal echo-
cardiography. We included patients with hemodynamic in-
stability who required intervention consisting of fluid
resuscitation or inotropic support. Pulmonary edema was
defined by the presence of pink frothy secretions on intub-
ation or changes on the chest X-ray (CXR). AFP was char-
acterized by the acute onset of areflexic limb weakness.
Controls were obtained from patients admitted with the
ICD code of HFMD, in the absence of severe disease. Con-
trols were matched in the ratio of 2:1 to cases for the year
of presentation and age.
Data comprising demographic characteristics, clinical
symptoms and signs, and laboratory findings were col-
lected through review of medical records. The following
symptoms were included: duration of fever, maximum
temperature recorded, presence of vomiting, oral ulcers,
rashes on the palms and soles, seizure, headache, history
of altered mentation, reduced feeding and evidence of
hypoperfusion as characterized by lethargy, syncope or
reported cool extremities. Vital signs were recorded and
compared to age-dependent normal ranges. The follow-
ing clinical signs were collected: presenting (and any de-
terioration of ) Glasgow Coma Score (GCS), presence of
seizure activity on arrival, signs of altered mental status,
poor peripheral perfusion, meningeal irritation, paralysis
and distribution of rashes. Laboratory findings studied
included: total white cell count with absolute neutrophil
and lymphocyte counts and EV-A71 status of stool,
throat swab and cerebrospinal fluid samples.
We summarized continuous variables in medians and
inter-quartile ranges (IQR). We reported categorical var-
iables as absolute numbers and proportions. Categorical
variables were analyzed by Fishers’ Exact test and con-
tinuous variables were analyzed by the Mann Whitney U
test. We performed a conditional univariable logistic re-
gression to find predictors that were discriminatory for
severe disease. Statistical significance was established as
p < 0.05 and the data were analyzed using STATA v12
(Stata Corp, College Station, Tx, USA).
Results
We identified a total of 24 cases of severe HFMD disease
during the study period, which were matched with 48 con-
trols. The median age of our patients (n = 72) was 2.4 (IQR
1.3-5.4) years. Among the cases, the median length of hos-
pital stay was 4 (IQR 3–7) days. Six children (25.0 %) were
admitted to intensive care unit (ICU) and the length of stay
ranged from 1 to 10 days. The patient with only 1 day of
ICU stay died shortly after admission. Out of those who
were admitted to ICU, 5 children required intubation for
prolonged seizure or poor GCS. Thirteen (54.2 %) patients
required fluid boluses at the emergency department (ED)
in view of tachycardia, hypotension or signs of poor periph-
eral perfusion. Among those who received fluid boluses,
the median average fluid volume received was 20 (IQR 10-
40 ml/kg and two of them required inotropes subsequently.
Seventeen (70.8 %) cases of severe HFMD were compli-
cated by central nervous system (CNS) disease, with en-
cephalitis being the most common complication. Among
those with CNS complications, 6 patients suffered residual
neurological deficit on discharge. Two of them developed
cerebellar signs while another 2 had lower limb weakness
with speech issues. One patient suffered cortical blindness
with motor deficit and 1 had right lower limb weakness.
Two patients with CNS complications had cardiopulmo-
nary collapse. One was successfully resuscitated. The
other patient who died had an accelerated course of ill-
ness. He presented with severe dehydration on day 3 of
sickness. After the initial fluid resuscitation in the ED, he
developed a seizure followed by cardiopulmonary arrest
on arrival to the ICU. The postmortem result of this pa-
tient showed evidence of encephalitis. Seven other cases
(29.2 %) had evidence of hemodynamic instability as evi-
denced by poor perfusion, tachycardia or hypotension re-
quiring initial fluid resuscitation but without evidence of
myocarditis following further investigations. Two out of
the 5 intubated patients had CXR changes suggestive of
pulmonary edema following endotracheal intubation.
The presence of high fever and a longer duration prior
to presentation were not significantly associated with a se-
vere course (Table 1). Neither did the presence of positive
contact history (56.5 % versus 41.7 %, p = 0.236) nor
vomiting (41.7 % vs 33.3 %, p = 0.494) predict for severe
disease. The severe cases were, however, associated with
symptoms of hypoperfusion (46 % vs 17 %, p = 0.012),
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seizure (50 % vs 2 %, p < 0.001) and altered mentation
(33 % vs 2 %, p = 0.016) in the presenting history.
Comparing the initial vital signs on arrival (Table 2),
children with severe HFMD had a significantly higher
heart rate and respiratory rate, especially among infants
and children aged less than 5 years. However, there was
no significant difference in the blood pressure at presen-
tation. The severe cases had a higher incidence of having
GCS of less than 15 on arrival (Table 3). Four had de-
terioration in GCS in the ED subsequently. All patients
in the control group had normal GCS with no subse-
quent deterioration. Higher incidence of seizure, altered
mental state, poor peripheral perfusion and meningeal
irritation were also observed among the severe cases.
More controls than cases presented with the full
spectrum of typical rash on the hands and feet, and with
oral ulcers. However, the absence of oral ulcers was not
associated with severe disease (Table 3).
Raised total white blood cell count (14.54 vs 8.27,
p = 0.003) and absolute neutrophil count (9.08 vs
4.49 p = 0.004) were associated with a more severe
course of HFMD (Table 4). There was a higher rate of
EV-A71 positivity among cases than controls (38 % vs
15 %, p = 0.031). Most of the positive swabs were obtained
from the throat. Hyperglycaemia (glucose >8.3 mmol/L,
or 150 mg/dL) were observed in 3 out of 17 severe cases
with documented blood glucose. Among the cases, 15
(62.5 %) had a lumbar puncture performed. There was no
bacterial growth from the cerebrospinal fluid samples ob-
tained. Six patients (25.0 %) had a magnetic resonance im-
aging performed, of which 3 revealed abnormal signals in
the posterior or temporal parietal regions.
Discussion
In this study, we identified 8 risk factors associated with se-
vere HFMD, namely the presence of evidence of hypoper-
fusion, seizure, altered mentation (both on the presenting
history and physical examination), meningeal irritation,
tachycardia, tachypnea, raised total white blood cell (specif-
ically absolute neutrophil count) and EV-A71 positivity.
Evidence of hypoperfusion, increased respiratory rate,
raised total white blood cell and positive EV-A71 are con-
sistent with other studies [7–9, 11]. Out of these risk fac-
tors, seizure, altered mentation and meningeal irritation,
are themselves signs of CNS complications.
More than a decade ago in a study done in our popu-
lation [5], atypical physical findings, raised total white
cell count, vomiting and the absence of mouth ulcers
were reported as predictive factors for a fatal course of
HFMD. This study, which involved a total of 138 pa-
tients with 7 fatalities, compared the fatal and non-fatal
cases of HFMD. In our current study comparing a larger
number of severe HFMD patients to controls, vomiting
and absence of oral ulcers, did not reach statistical sig-
nificance. We found only one fatality related to severe
HFMD over the last one decade. This is significantly lower
than the seven fatalities reported by Chong et al. [5] dur-
ing and after the epidemic of HFMD in 2000. Since then,
the mortality and overall morbidity has significantly re-
duced in our country. This is very likely to be contributed
by the better infectious disease control measures insti-
tuted especially at the level of childcare centres, greater
awareness and earlier health seeking behavior.
We observed that the majority (75 %) of the severe
HFMD were children less than 5 years old. Young age
Table 1 Demographic data and presenting history
Cases (n = 24) Controls (n = 48) OR (95 % CI) P valuea
Demographics
Age (year) median (IRQ) 3.0 (1.5;5.5) 2.5 (1;5.5) 1.04 (0.70;1.55) 0.848
Female 15 (63 %) 26 (54 %) 0.72 (0.27;1.92) 0.506
Presenting History
Level of fever (°C) (N = 23 vs 42) median (IQR) 39 (38.7;39.4) 39 (38.5;39.5) 1.06 (0.49;2.25) 0.888
Temperature≥ 39 °C 17 (74 %) 24 (57 %) 2.19 (0.69;6.96) 0.183
Temperature < 39 °C 6 (26 %) 18 (43 %)
Duration of fever (days) 3.3 (2.0) 2.4 (1.6) 1.27 (0.97;1.67) 0.077
Contact history (N = 23 vs 48) 13 (57 %) 20 (42 %) 1.94 (0.65;5.79) 0.236
Vomiting 10 (42 %) 16 (33 %) 1.42 (0.52;3.86) 0.494
Symptoms of hypoperfusionc 11 (46 %) 8 (17 %) NC 0.012b
Seizure 12 (50 %) 1 (2 %) NC <0.001b
Altered mentation 8 (33 %) 3 (6 %) 13.11 (1.61;106.60) 0.016
NC non-computable
afrom conditional logistic regression
bfrom Fisher’s exact test
cas characterized by lethargy, syncope or reported cool extremities
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Table 2 Vital signs at presentation
Initial vital signs Cases (n = 24) Controls (n = 48)
Median (IQR) Median (IQR) OR (95 % CI) P value
<1 year 1- 4.99 years 5-9.99 years >10 years <1 year 1- 4.99 years 5-9.99 years >10 years
n = 3 n = 14 n = 5 n = 2 n = 6 n = 28 n = 10 n = 4
Heart rate (beats/min) 184 (170;200) 152 (131;173) 115(104;119) 117 (81;153) 146 (120;178) 123 (109;157) 112 (109;120) 109.5 (86.5;116.0) 1.02 (1.00;1.05) 0.021
Respiratory rate
(breath/min)
40 (36;46) 30 (26;32) 25 (22;28) 31 (18;44) 35 (34;38) 30 (24;30) 20 (20;22) 20 (18;21) 1.15 (1.01;1.29) 0.03
Systolic blood pressure
(mmHg) (N = 24 vs 46)a
100 (75;111) 106 (96;118) 114 (91;121) 120.5 (108;133) 106 (87;110) 100 (87;108) 107.5 (100.0;129.0) 114 .0(104.5;115.5) 1.03 (0.99;1.07) 0.16
Diastolic blood pressure
(mmHg) (N = 24 vs 46)a
50 (49;67) 64.5(53.0;78.0) 65 (60;71) 65 (62;68) 54 (46;63) 65 (58;70) 66 (57;68) 68.5 (63.5;73) 1.01 (0.96;1.05) 0.819
Pulse oximetry
reading (%)
97 (96;100) 98.5 (98.0;100.0) 100 (100;100) 96.5 (95;98.5) 100 (99;100) 99 (98;100) 99 (99;99) 100 (99;100) 0.69 (0.48;0.97) 0.032
Temperature on
arrival (°C)
38.40 (37.90;39.50) 38.55 (37.40;39.10) 36.3 (36.3;37.6) 36.8 (36.5;37.1) 38.05 (37.4;38.0) 37.20 (36.85;37.95) 37.85 (37.1;38.9) 37 (36.7;37.1) 1.32 (0.84;2.09) 0.227














has been reported to be associated with severe HFMD
[8, 11, 13, 14]. This could be attributed to the low herd
immunity in children less than 5 years old [15].
Recent studies surveying risk factors for severe HFMD
have emerged [7–9] mainly from China, which has a
high disease burden from HFMD [1]. A recent meta-
analysis involving 19 separate studies [11] found that
clinical characteristics such as young age, home care,
duration of fever ≥ 3 days, body temperature ≥ 37.5 C,
lethargy, vomiting, hyperglycemia, increased neutrophil
count and EV-A71 infection were significantly related to
the risk of severe HFMD. Our population differs from the
HFMD population in China, in that our prevalence of se-
vere cases tends to be lower, our patients are older [7, 8],
and we have a lower incidence of EV-A71 infection [9].
One study in China involving 176 children, aged 6 to
45 months, demonstrated a relatively high incidence of
severe HFMD complicated by cardiopulmonary collapse
(18 %). This study observed that children with severe
HFMD and circulatory collapse often had high blood
pressure and heart rate in the early stage. The two
patients with CNS involvement in our study who had
cardiopulmonary collapse demonstrated tachycardia with
normal blood pressure on arrival at the ED. Tachycardia
can be a sign of autonomic dysfunction from CNS com-
plications or may be a sign of cardiac involvement.
Screening children with severe HFMD for these abnor-
mal vital signs is important in predicting impending car-
diorespiratory failure and allowing the timely initiation
of appropriate interventions. Such patients should re-
ceive close inpatient monitoring by nursing staff who are
familiar with age-appropriate vital sign norms, frequent
charting of vital signs and GCS, and an early consider-
ation of the need for hemodynamic support.
The 2 patients who had evidence of pulmonary edema
on CXR had encephalitis with cardiopulmonary collapse.
Both of them received a total of 40 ml/kg of resuscita-
tion fluids each during the initial stage. Damage to cer-
tain areas in the brain stem in encephalitis can cause
neurogenic pulmonary edema. Several mechanisms that
have been proposed to explain the pathogenesis of
neurogenic pulmonary edema include an increase in pul-
monary vascular pressure and an increase in pulmonary
endothelial permeability [16]. Fulminant neurogenic pul-
monary edema had been reported in patients who died
from HFMD in Malaysia and Taiwan [13, 17]. In view of
the risk of neurogenic pulmonary edema in HFMD pa-
tients with CNS involvement, fluid resuscitation, when
indicated, should be given judiciously to prevent fluid-
overloading of the lungs.
We acknowledge the limitations of our study. Firstly, a
case–control methodology was chosen because of the
low event rate of severe HFMD in our population.
Across the years, there may have been differences in the
diagnosis and management of these patients. Also, by
age-matching, we sought to search for red flags in the
respective age strata that would guide the ED physician.
By age-matching, however, the effect of age on the re-
spective variables could not be studied. With retrospect-
ive studies, results could be confounded by information
Table 4 Results of investigations
Investigations Cases (n = 24) Controls (n = 48) OR (95 % CI) P value
Initial Full Blood Count (N = 24 versus 31)
Total white cell count, median (IQR) 14.54 (11.0; 18.20) 8.27 (7.02;8.27) 1.36 (1.11;1.66) 0.003
Absolute neutrophil count, median (IQR) 9.08 (6.51;12.09) 4.49 (3.37;4.49) 1.38 (1.11;1.71) 0.004
Absolute lymphocyte count, median (IQR) 2.81(2.39;4.43) 2.60(2.07;2.60) 1.28 (0.89;1.85) 0.18
EV-A71 Status
Positive 9/24 (38 %) 7/48 (15 %) 10.28 (1.24;85.21) 0.031
Stool N (%)a 2/9 (22 %) 1/7 (14 %)
Throat swab N (%)a 8/9 (89 %) 7/7 (100 %)
CSF N (%)a 0/9 (0 %) 0/9 (0 %)
aNumbers are accounted for because some patients had more than 1 specimen site tested
Table 3 Clinical signs at presentation
Cases (n = 24) Controls (n = 48) p valuea
GCS < 15 at presentation 7 (29 %) 0 (0 %) <0.001
Deterioration in GCSa 4 (17 %) 0 (0 %) 0.010
Seizure on arrival 6 (25 %) 0 (0 %) 0.001
Altered mentation 11 (46 %) 0 (0 %) <0.001
Poor peripheral
perfusion
8 (33 %) 0 (0 %) <0.001
Distribution of rash and
presence of ulcers
(N = 23 vs 48)
Typical hands and feet
rash and oral ulcers
15 (63 %) 41 (85 %) 0.037
Absence of oral ulcers 6 (25 %) 4 (8 %) 0.066
Meningeal irritation 4 (17 %) 0 (0 %) 0.010
aAny drop in GCS
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bias (chart reviewers were not blinded to the objective of
the study). Finally, given the small number of cases, it
was statistically inappropriate to perform a multivariable
analysis to derive independent risk factors.
Conclusions
The presence of evidence of hypoperfusion, tachycardia,
and tachypnea may herald severe disease and should
alert physicians assessing young children with HFMD.
Physicians should be particularly cognizant of signs of
CNS complications among children with HFMD, espe-
cially seizure, altered mentation and meningeal irritation.
Particular care should be taken in the presence of raised
total white blood cell (specifically absolute neutrophil
count) and EV-A71 positivity. Patients with such risk
factors should be observed closely with careful monitor-
ing of their vital signs and GCS. Any clinical deterior-
ation should prompt early institution of supportive care
eg airway support, measured fluid resuscitation and ino-
tropic support. In addition, we propose that in patients
with likely central nervous system involvement, fluids
should be managed judiciously because of their risk for
pulmonary edema. Future work in this area should in-
clude comparative studies of severe HFMD disease in
different populations.
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